Stay updated on iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Sign up to get notified when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.

Latest updates to the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check28 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check43 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of various organic chemical compounds and drugs like atezolizumab and ADI PEG20. Notably, the revision number has been updated to v3.0.0, indicating a major change.SummaryDifference3%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.